Extending Lifespan, Improving Health
ABOUT US
AGELESS BIO is the first German enterprise to explore potential solutions to aging. Our research scientists work around-the-clock to bring to a clinic near you the most advanced, cutting-edge technologies capable of bridging the multifaceted nature of the natural aging process. Our human rejuvenation technology will not only extend your lifespan, but it will also improve your quality of life throughout your life. AGELESS BIO’s ground-breaking innovations promise to bring about a paradigm shift in the human rejuvenation field.
OUR TECHNOLOGIES
NEURONAL DEFENSE THERAPIES
At AGELESS BIO we are developing revolutionary stem cell treatments that are based on the evolutionary evolved mechanisms employed by regenerating organisms like the flatworm and axolotls. Our technology allows these stem cells to circulate throughout the human body to locate afflicted areas and to repair those areas without triggering an immune response. Thus, our technology has the potential to regenerate physical damages to the body as well as to replenish the population of adult stem cells in the body that has been depleted by the natural process of aging.
Extending Lifespan, Improving Health
AGELESS BIO treats the multifaceted nature of the aging process using a series of strategic biological tools to extend lifespan while improving the overall health of the individual.
REGENERATIVE STEM CELL THERAPIES
Aging affects the brain. At AGELESS BIO we are developing neuronal defense therapies to treat not only the aging brain but also other age-related neuronal diseases. AGELESS BIO has developed the Brain-Rinse, a patented, non-invasive medical device designed to support cerebrospinal fluid transport and the brain’s natural waste-clearance processes. The technology is being advanced toward clinical trials to evaluate safety, feasibility, target engagement, and early clinical effects. Because impaired CSF dynamics and waste clearance are implicated across a wide range of neurological disorders, Brain-Rinse has the potential to become a platform technology relevant to more than 42 neurological conditions and diseases, including Alzheimer’s disease, Parkinson’s disease, dementia, multiple sclerosis, and traumatic brain injury.
We are now preparing the next stage of development and clinical validation and are actively seeking strategic investors and partners to help fund the trial program, accelerate regulatory development, and support the transition toward early production.
SENOLYTIC THERAPIES
AGELESS BIO is currently developing various targeted senolytic therapies. These therapies remove old, dysfunctional, or senescent cells, which then allows the body to replace them with new healthy and better-functioning cells. Studies have shown that the removal of these senescent cells slows down the aging process.
GENE THERAPIES
At AGELESS BIO we are also developing gene therapy vectors to repair the telomeres and other age-related problems. Our gene therapy could also be applied towards correcting congenital genetic diseases in vivo.
Our vision is the establishment of longevity clinics in an area near you. These clinics will facilitate personalized therapeutic treatments utilizing our own patented anti-aging products and gene-based life-extending technologies.
OUR VISION
Easy Access to a Better Life
Research and development are costly and time-consuming endeavors. If getting older concerns you and you believe in our cause, then here is your chance to make a difference! Hasten the clinical availability of our therapeutic discoveries by financially supporting the research efforts by either donating with the PayPal link below, or by contacting us for a more substantial investment opportunity. If financial support is beyond your means, we ask that you please support us by making family and friends aware of us. Every little helps and we appreciate all the support. Thank you!
INVESTMENT
Empower Research, Empower Life
Get in touch
Term and Conditionds
Copyright © 2018 AGELESS BIO. All rights reserved.